摇头丸：3,4－亚甲基二氧甲基苯丙胺和4,5－亚甲基二氧基苯丙胺综述
Ecstacy: a review of MDMA and MDA.
作者信息
Climko R P, Roehrich H, Sweeney D R, Al-Razi J
出版信息
Int J Psychiatry Med. 1986;16(4):359-72. doi: 10.2190/dcrp-u22m-aumd-d84h.
The Drug Enforcement Administration classified the drug methylenedioxymethamphetamine, MDMA, also known as Ecstacy, as a Schedule I controlled substance on July 1, 1985. The controversy surrounding the classification of MDMA is related to the question of its efficacy as an adjunct to psychotherapy and the larger issue of how to regulate the production and use of designer drugs. The authors review the literature on MDMA and its predecessor, MDA, a substance that differs from MDMA by one methyl group.
1985年7月1日，美国药品管理局将亚甲二氧基甲基苯丙胺（MDMA），即俗称的摇头丸，列为第一类管制物质。围绕MDMA分类的争议涉及到它作为心理治疗辅助药物的疗效问题，以及如何管制合成毒品生产和使用这一更大的问题。作者回顾了关于MDMA及其前身甲烯二氧苯丙胺（MDA，一种与MDMA相差一个甲基的物质）的文献。
Zotero 插件